Your browser doesn't support javascript.
loading
Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide.
Byrgazov, Konstantin; Anderson, Claes; Salzer, Benjamin; Bozsaky, Eva; Larsson, Rolf; Gullbo, Joachim; Lehner, Manfred; Lehmann, Fredrik; Slipicevic, Ana; Kager, Leo; Fryknäs, Mårten; Taschner-Mandl, Sabine.
Afiliação
  • Byrgazov K; Oncopeptides AB, Luntmakragatan 46, Stockholm, SE-111 37, Sweden.
  • Anderson C; Department of Medical Sciences, Division of Cancer Pharmacology and Computational Medicine, Uppsala University, Uppsala, Sweden.
  • Salzer B; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
  • Bozsaky E; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
  • Larsson R; Department of Medical Sciences, Division of Cancer Pharmacology and Computational Medicine, Uppsala University, Uppsala, Sweden.
  • Gullbo J; Oncopeptides AB, Stockholm, Sweden.
  • Lehner M; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
  • Lehmann F; Oncopeptides AB, Stockholm, Sweden.
  • Slipicevic A; Oncopeptides AB, Stockholm, Sweden.
  • Kager L; Department of Pediatrics, St. Anna Children's Hospital, Medical University of Vienna and Children's Cancer Research Institute (CCRI), Vienna, Austria.
  • Fryknäs M; Department of Medical Sciences, Division of Cancer Pharmacology and Computational Medicine, Uppsala University, Uppsala, Sweden.
  • Taschner-Mandl S; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
Ther Adv Med Oncol ; 12: 1758835920937891, 2020.
Article em En | MEDLINE | ID: mdl-32774473
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article